SAMSUNG PHARM. Co., LTD. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operating Revenue	44,294	51,955	46,484	41,919	47,194
Other Revenue	-	-	-	-	0
Revenue	44,294	51,955	46,484	41,919	47,194
Revenue Growth (YoY)	-14.74%	11.77%	10.89%	-11.18%	11.93%
Cost of Revenue	-	-	37,903	36,851	38,425
Gross Profit	44,294	51,955	8,580	5,069	8,770
Selling, General & Admin	-	-	12,228	11,708	15,001
Research & Development	-	-	377.51	938.79	898.61
Amortization of Goodwill & Intangibles	-	-	18.92	246.65	1,034
Other Operating Expenses	29,465	33,918	755.65	261.64	475.91
Operating Expenses	29,465	33,918	13,980	12,843	15,096
Operating Income	14,829	18,037	-5,399	-7,774	-6,327
Interest Expense	-	-	-1,357	-2,590	-2,456
Interest & Investment Income	-	-	1,246	692.21	323.74
Currency Exchange Gain (Loss)	-	-	-9.87	-26.54	45.02
Other Non Operating Income (Expenses)	-2,117	5,638	273.82	-870.64	-1,665
EBT Excluding Unusual Items	12,711	23,675	-5,246	-10,569	-10,079
Gain (Loss) on Sale of Investments	-	-	3,203	-117.01	-3,605
Gain (Loss) on Sale of Assets	-	-	27	292.49	13.04
Asset Writedown	-	-	-	-577.53	-3,067
Other Unusual Items	-	-	-	5.46	-609.29
Pretax Income	12,711	23,675	-2,016	-10,966	-17,348
Income Tax Expense	-	-1,137	59.55	-3,692	-129.71
Earnings From Continuing Operations	12,711	24,812	-2,076	-7,274	-17,218
Earnings From Discontinued Operations	-	-	-	-265.93	-4,400
Net Income to Company	12,711	24,812	-2,076	-7,540	-21,618
Minority Interest in Earnings	-	-	-	-0	0
Net Income	12,711	24,812	-2,076	-7,540	-21,618
Net Income to Common	12,711	24,812	-2,076	-7,540	-21,618
Net Income Growth	-48.77%	-	-	-	-
Shares Outstanding (Basic)	-	-	51	40	33
Shares Outstanding (Diluted)	-	-	51	40	33
Shares Change (YoY)	-	-	28.44%	21.80%	28.46%
EPS (Basic)	-	-	-40.51	-189.00	-660.00
EPS (Diluted)	-	-	-40.51	-189.00	-660.00
Free Cash Flow	-	-	-9,134	-956.01	-43,177
Free Cash Flow Per Share	-	-	-178.27	-23.96	-1318.23
Gross Margin	100.00%	100.00%	18.46%	12.09%	18.58%
Operating Margin	33.48%	34.72%	-11.62%	-18.55%	-13.41%
Profit Margin	28.70%	47.76%	-4.46%	-17.99%	-45.80%
Free Cash Flow Margin	-	-	-19.65%	-2.28%	-91.49%
EBITDA	-	-	-1,635	-3,859	-2,060
EBITDA Margin	-	-	-3.52%	-9.21%	-4.37%
D&A For EBITDA	-	-	3,764	3,915	4,267
EBIT	14,829	18,037	-5,399	-7,774	-6,327
EBIT Margin	33.48%	34.72%	-11.62%	-18.55%	-13.41%
Advertising Expenses	-	-	921.87	150.94	975.62

Updated Nov 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.